Testing effectiveness (Phase 2)Study completedNCT03453489
What this trial is testing
AMT-PET in Monitoring Telotristat Etiprate Treatment in Participants With MetastaticNeuroendocrine Neoplasm
Who this might be right for
Carcinoid SyndromeMetastatic Nonfunctional Well Differentiated Neuroendocrine Neoplasm
Barbara Ann Karmanos Cancer Institute 4